Back to Search
THOMAS AMATRUDA, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1427068618IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
35894(MN)
Education
YALE UNIVERSITY SCHOOL OF MEDICINE
Class of 1978
Research & Publications (4)
Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047A.
PMID 19090009·Cancer·2009
3-trial
Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma.
PMID 16809738·J Clin Oncol·2006
3-trial
Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients.
PMID 16489066·Clin Cancer Res·2006
8-other
Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial.
PMID 16258104·J Clin Oncol·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 480 OSBORNE RD NE, SUITE 220
FRIDLEY, MN 55432 - Phone
- (763) 786-1620
Quick Facts
- NPI
- 1427068618
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 48
- Publications
- 4
Are you this provider?
Claim Your Profile